BlueReg can support with routine pharmacovigilance (PV) activities for early access programs, clinical trials or post-marketing. The team can support you with : 

  • PV case processing (recordings, database entry, case translation and follow-up)
  • Establish causality assessment for PV cases
  • Submission to competent authorities
  • Literature review

“All these activities are carried out in full compliance with Good Vigilance Practices and local standards.”

Our experts

Associated News

The French system for preventing and managing shortages

The French regulation on the prevention and management of stock shortages of medicinal products is...

Learn more

New Appointment to our Leadership Team !

BlueReg Group is delighted to announce the appointment of Dominique Patrone as General Manager of PharmaBlue....

Learn more

BlueReg’s team will be pleased to meet you at BioFit Lille, on booth F10

Event location: Lille, France  Event date: Tuesday, December 4, 2018 to Wednesday, December 5, 2018 ...

Learn more